Related Experiment Video
Updated: Dec 27, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
Published on: October 4, 2022
Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic Cancer Cells Through Stimulation of Src
Jungwhoi Lee1, Jungsul Lee2, DA Hye Kim3
1Department of Applied Life Science, SARI, Jeju National University, Jeju-do, Republic of Korea sdjd1108@kaist.ac.kr kimjh@jejunu.ac.kr.
Background/Aim:
The prognosis of pancreatic cancer has not improved due to its migratory feature and refractory potential to chemo-resistance with absence of effective diagnosis. Despite continuous efforts, its underlying mechanisms of malignant nature remain ambiguous. The objective of this study was to investigate delta-like 1 (DLL1) as a tumor suppressor in the metastasic ability of human pancreatic cancer cells.
Materials And Methods:
Cellular expression of DLL1 was demonstrated using the GEO public database and western blot analysis. The biological function of DLL1 was validated by biological behavior analysis. Prognosis to DLL1 expression was demonstrated using analysis of the GEO public database.
Results:
Analysis using the GEO database and western blotting showed higher DLL1 mRNA and protein expression levels in pancreatic cancer compared to those in normal pancreas. DLL1 was uniquely expressed in seven human pancreatic cancer cell lines compared to human pancreatic duct epithelial H6c7 cells. Ablation of DLL1 expression stimulated migration and invasion by activating Src and p38 phosphorylation, but not viability and chemo-resistance of human pancreatic cancer cells. In addition, expression of DLL1 was correlated with migratory features of pancreatic cancer in vivo. Moreover, high DLL1 expression was associated with a favorable prognosis in pancreatic cancer patients.
Conclusion:
DLL1 is a potent suppressor of pancreatic cancer metastasis. Understanding correlation between expression and function of DLL1 might contribute to our knowledge of the complicated mechanism of pancreatic cancer metastasis.
Insights
Delta-like 1 (DLL1) suppresses pancreatic cancer metastasis by inhibiting cell migration and invasion. High DLL1 expression correlates with a better prognosis in pancreatic cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic cancer prognosis remains poor due to metastasis and chemo-resistance, with unclear underlying mechanisms.
- Delta-like 1 (DLL1) is investigated for its role in the metastatic potential of human pancreatic cancer cells.
Purpose of the Study:
- To investigate the function of delta-like 1 (DLL1) as a tumor suppressor in human pancreatic cancer cell metastasis.
Main Methods:
- Analyzed DLL1 expression using GEO public database and western blot.
- Validated DLL1's biological function through cell behavior analysis.
- Correlated DLL1 expression with patient prognosis using the GEO public database.
Main Results:
- DLL1 mRNA and protein were upregulated in pancreatic cancer tissues and cell lines.
- DLL1 ablation enhanced migration and invasion by activating Src and p38 phosphorylation.
- DLL1 expression correlated with reduced in vivo metastasis and a favorable patient prognosis.
Conclusions:
- DLL1 acts as a potent suppressor of pancreatic cancer metastasis.
- Understanding DLL1's expression-function correlation advances knowledge of pancreatic cancer metastasis mechanisms.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

